From: Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
Variable | Level | aOR [95% CI] | |
---|---|---|---|
First booster | Second booster | ||
Sex | Female | Ref | Ref |
Male | 0.93 [0.88; 0.98] | 1.07 [1.04; 1.11] | |
Age group | 18–24 | Ref | NA |
25–34 | 1.13 [1.04; 1.23] | NA | |
35–44 | 1.41 [1.29; 1.54] | NA | |
45–54a or 50–54b | 2.09 [1.91; 2.29] | Ref | |
55–64 | 3.31 [3.00; 3.64] | 1.71 [1.63; 1.79] | |
65–74 | 5.56 [4.94; 6.27] | 3.56 [3.39; 3.75] | |
75–84 | 5.69 [4.91; 6.59] | 4.91 [4.61; 5.23] | |
85 + | 5.23 [4.24; 6.45] | 5.63 [5.14; 6.16] | |
Region of residence | Flanders | Ref | Ref |
Brussels | 0.23 [0.21; 0.25] | 0.29 [0.27; 0.31] | |
Wallonia | 0.41 [0.39; 0.44] | 0.31 [0.30; 0.32] | |
Infection history | COVID-naïve | Ref | Ref |
At least 1 infect. before | 0.69 [0.63; 0.75]c | 0.87 [0.82; 0.92]d | |
1 infect. after | 0.33 [0.31; 0.36]c | 1.09 [1.03; 1.15]d | |
> 1 infect. after | 0.11 [0.03; 0.37]c | 0.46 [0.30; 0.71]d | |
> 1 infect. before & after | 0.17 [0.13; 0.21]c | 0.82 [0.69; 0.98]d |